Stanford University
Showing 441-450 of 667 Results
-
Sarvesh Periyasamy
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyBioResident in the Integrated Interventional Radiology Residency. I completed my Internship in General Surgery at Stanford Health Care (2024).
I am a former MD-PhD student part of the Medical Scientist Training Program (MSTP) at the University of Wisconsin School of Medicine and Public Health. I earned my PhD in Biomedical Engineering in the Image-Guided Interventions Lab under Dr. Paul Laeseke MD, PhD. My thesis work investigated novel X-ray based image guidance techniques and device development for image-guided interventions.
I am interested in a career where I can integrate advances in physics and engineering research into a translational career as a physician-scientist. My research interests focus on the development and use of advanced imaging techniques to improve diagnosis and intervention of a variety of vascular and oncologic diseases. -
Andrew Picel, MD
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsProstate artery embolization (PAE) for the treatment of lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH).
Prophylactic balloon occlusion catheters and uterine artery embolization to reduce blood loss in patients with invasive placenta.
Geniculate artery embolization for relief of osteoarthritis related knee pain. -
Edward Pimentel
Postdoctoral Scholar, Radiology
BioEdward Pimentel is a postdoctoral scholar in the lab of Prof. Tom Soh. After receiving his BS in Chemistry at BYU and pursuing the total synthesis of a natural product with anticancer activity in the lab of Dr. Merritt Andrus, Edward was the first graduate student in the lab of Dr. Jeffrey Martell, where his PhD work centered on using DNA nanostructures to accelerate catalytic reactions and building an ultrahigh-throughput DNA-encoded reaction screening platform. Now as a postdoctoral scholar, his research focuses on applying functional nucleic acids to solve problems in diagnostic and sensing for human health. In addition to his research, Edward is a passionate mentor and has been involved in mentoring programs at every stage of his career. He is now a coordinator for the SURPAS Someone Like Me Peer Mentoring program.
-
Laura Jean Pisani, Ph.D.
Physical Science Research Scientist, Radiology - Diagnostic Radiology
Current Role at StanfordAssociate Director of Stanford Center for Innovation in In vivo Imaging (SCi3), Radiology
Member, Molecular Imaging Program at Stanford -
Sharon Pitteri
Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Current Research and Scholarly InterestsThe Pitteri laboratory is focused on the discovery and validation of proteins that can be used as molecular indicators of risk, diagnosis, progression, and recurrence of cancer. Proteomic technologies, predominantly mass spectrometry, are used to identify proteins in the blood that are differentially regulated and/or post-translationally modified with disease state. Using human plasma samples, tumor tissue, cancer cell lines, and genetically engineered mouse models, the origins of these proteins are being investigated. A major goal of this research is to define novel molecular signatures for breast and ovarian cancers, including particular sub-types of these diseases. This laboratory is also focused on the identification of proteins with expression restricted to the surface of cancer cells which can be used as novel targets for molecular imaging technologies.
-
Sylvia K. Plevritis, PhD
William M. Hume Professor in the School of Medicine, Professor of Biomedical Data Science and of Radiology
Current Research and Scholarly InterestsMy research program focuses on computational modeling of cancer biology and cancer outcomes. My laboratory develops stochastic models of the natural history of cancer based on clinical research data. We estimate population-level outcomes under differing screening and treatment interventions. We also analyze genomic and proteomic cancer data in order to identify molecular networks that are perturbed in cancer initiation and progression and relate these perturbations to patient outcomes.
